Ambiq (AMBQ) director’s entity sells 70,592 shares in open-market trades
Rhea-AI Filing Summary
Ambiq Micro, Inc. director Timothy Chen reported a series of open-market sales of the company’s common stock on May 27, 2026. In total, an entity named Triumph Way Investment Inc., over which Chen exercises sole voting and dispositive control, sold 70,592 shares at weighted-average prices ranging from about $78 to $82 per share.
Following these transactions, Chen continues to hold 47,618 Ambiq Micro shares directly, according to the filing. The sales were executed in multiple trades at different prices within specified ranges, with full price details available on request from the company or the SEC staff.
Positive
- None.
Negative
- None.
Insights
Director-linked entity sells 70,592 Ambiq shares while Chen retains a direct stake.
The filing shows an entity associated with director Timothy Chen, Triumph Way Investment Inc., completed open-market sales totaling 70,592 shares of Ambiq Micro common stock on May 27, 2026. Reported weighted-average prices span roughly $78 to just over $81 per share across four sale groupings.
Chen retains 47,618 shares in a direct position after these transactions, indicating he still has meaningful equity exposure, though the filing does not quantify his prior holdings. The trades are standard open-market sales, with no derivatives exercised and no remaining derivative positions listed in this report.
The price fields are disclosed as weighted averages, and the filing notes that more granular trade data by exact price level is available upon request. Subsequent company filings may provide additional context on Chen’s overall ownership trend and any future insider activity.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 22,414 | $78.85 | $1.77M |
| Sale | Common Stock | 24,248 | $79.72 | $1.93M |
| Sale | Common Stock | 20,666 | $80.61 | $1.67M |
| Sale | Common Stock | 3,264 | $81.57 | $266K |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $78.29 to $79.26 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The Reporting Person exercises sole voting and dispositive control over the shares held by Triumph Way Investment Inc. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $79.30 to $80.28 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $80.30 to $81.27 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $81.325 to $81.755 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.